ProQR Therapeutics N.V.
PRQRNASDAQ
Healthcare
Biotechnology
$1.72
+0.01(0.3%)
52W $1.12 – $3.05
Quick:
SCHEDULE 13D/A
Feb 6, 2026 (1 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G
Jan 20, 2026 (2 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Sep 30, 2025 (6 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13D/A
Sep 4, 2025 (7 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13D/A
Aug 20, 2025 (7 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G/A
Aug 12, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D
May 28, 2025 (10 months ago)SCHEDULE 13D
SEC filing disclosure
Filing details and context
SCHEDULE 13G/A
May 12, 2025 (10 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active